Overview of the 3rd isirv-Antiviral Group Conference - advances in clinical management.

This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv- Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS- Co V, respiratory syncytial virus ( RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted. [ABSTRACT FROM AUTHOR]